What should you know about RET-positive lung cancer?

RET-positive lung cancer is lung cancer whose cells carry a RET gene change that may guide treatment with a RET-targeted medicine. The change is usually identified from tumour tissue or a blood sample using molecular testing. It describes a feature of the cancer cells, rather than a symptom or a separate type of lung organ. Your care team combines this result with the cancer's stage, subtype, overall health, and your preferences.

RET is a gene that helps control signals involved in cell growth. In some lung cancers, a rearrangement or other change involving RET can keep growth signals switched on. A laboratory report may call this a RET fusion or RET alteration. The result can help an oncology team select medicines designed to block that signal.

RET status is different from the cancer's stage. Staging checks where the cancer is in the body, including whether it has spread beyond the lung. Molecular testing can be part of genomic tumour profiling, alongside tests for other changes that may affect treatment.

Ask whether the laboratory found a confirmed RET fusion, which sample was tested, and whether the result is sufficient to make a treatment decision. Your oncologist may discuss a RET-targeted tablet, treatment for symptoms, or another approach depending on the stage and previous care. Treatment plans can change if scans show a different response or if side effects arise.

Keep a record of new symptoms and medicines, including non-prescription products. Tell the team about changes in breathing, cough, voice, vision, balance, or alertness. Follow the prescribed schedule and report troublesome effects early; the team may adjust treatment or provide supportive care.

Contact your oncology team promptly for worsening breathlessness, chest pain, coughing blood, a new or persistent hoarse voice, fever, or difficulty swallowing. Seek urgent medical help for severe breathing difficulty, sudden weakness on one side, a seizure, new confusion, fainting, or a sudden severe headache. These symptoms need assessment because lung cancer or its treatment can affect the lungs, nerves, or other body systems; they do not by themselves confirm what is causing them.

Useful questions include: What exact RET change was found? Was the test done on tumour tissue, blood, or both? What is the cancer stage and subtype? Which treatment fits my results, and how will we monitor it? Which side effects should be reported the same day? Should I have brain imaging or other scans as part of staging or follow-up?